pyruvaldehyde has been researched along with 2019 Novel Coronavirus Disease in 4 studies
Pyruvaldehyde: An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.
methylglyoxal : A 2-oxo aldehyde derived from propanal.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pathogenesis of coronavirus disease 2019 (COVID-19) is associated with a hyperinflammatory response." | 5.91 | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein S1 Induces Methylglyoxal-Derived Hydroimidazolone/Receptor for Advanced Glycation End Products (MG-H1/RAGE) Activation to Promote Inflammation in Human Bronchial BEAS-2B Cells. ( Antognelli, C; Bozza, S; Costantini, C; Graziani, A; Manfredelli, D; Pariano, M; Puccetti, P; Romani, L; Talesa, VN, 2023) |
| "The pathogenesis of coronavirus disease 2019 (COVID-19) is associated with a hyperinflammatory response." | 1.91 | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein S1 Induces Methylglyoxal-Derived Hydroimidazolone/Receptor for Advanced Glycation End Products (MG-H1/RAGE) Activation to Promote Inflammation in Human Bronchial BEAS-2B Cells. ( Antognelli, C; Bozza, S; Costantini, C; Graziani, A; Manfredelli, D; Pariano, M; Puccetti, P; Romani, L; Talesa, VN, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alomar, FA | 4 |
| Alshakhs, MN | 1 |
| Abohelaika, S | 1 |
| Almarzouk, HM | 1 |
| Almualim, M | 1 |
| Al-Ali, AK | 1 |
| Al-Muhanna, F | 1 |
| Alomar, MF | 1 |
| Alhaddad, MJ | 1 |
| Almulaify, MS | 1 |
| Alessa, FS | 1 |
| Alsalman, AS | 1 |
| Alaswad, A | 1 |
| Bidasee, SR | 1 |
| Alsaad, HA | 1 |
| Alali, RA | 1 |
| AlSheikh, MH | 1 |
| Akhtar, MS | 1 |
| Al Mohaini, M | 1 |
| Alsalman, AJ | 1 |
| Alturaifi, H | 1 |
| Bidasee, KR | 1 |
| Di Martino, D | 1 |
| Cappelletti, M | 1 |
| Tondo, M | 1 |
| Basello, K | 1 |
| Garbin, C | 1 |
| Speciani, A | 1 |
| Ferrazzi, E | 1 |
| Manfredelli, D | 1 |
| Pariano, M | 1 |
| Costantini, C | 1 |
| Graziani, A | 1 |
| Bozza, S | 1 |
| Romani, L | 1 |
| Puccetti, P | 1 |
| Talesa, VN | 1 |
| Antognelli, C | 1 |
1 review available for pyruvaldehyde and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Methylglyoxal in COVID-19-induced hyperglycemia and new-onset diabetes.
Topics: COVID-19; Diabetes Mellitus; Humans; Hyperglycemia; Insulin; Magnesium Oxide; Pyruvaldehyde; SARS-Co | 2022 |
Methylglyoxal in COVID-19-induced hyperglycemia and new-onset diabetes.
Topics: COVID-19; Diabetes Mellitus; Humans; Hyperglycemia; Insulin; Magnesium Oxide; Pyruvaldehyde; SARS-Co | 2022 |
Methylglyoxal in COVID-19-induced hyperglycemia and new-onset diabetes.
Topics: COVID-19; Diabetes Mellitus; Humans; Hyperglycemia; Insulin; Magnesium Oxide; Pyruvaldehyde; SARS-Co | 2022 |
Methylglyoxal in COVID-19-induced hyperglycemia and new-onset diabetes.
Topics: COVID-19; Diabetes Mellitus; Humans; Hyperglycemia; Insulin; Magnesium Oxide; Pyruvaldehyde; SARS-Co | 2022 |
Methylglyoxal in COVID-19-induced hyperglycemia and new-onset diabetes.
Topics: COVID-19; Diabetes Mellitus; Humans; Hyperglycemia; Insulin; Magnesium Oxide; Pyruvaldehyde; SARS-Co | 2022 |
Methylglyoxal in COVID-19-induced hyperglycemia and new-onset diabetes.
Topics: COVID-19; Diabetes Mellitus; Humans; Hyperglycemia; Insulin; Magnesium Oxide; Pyruvaldehyde; SARS-Co | 2022 |
Methylglyoxal in COVID-19-induced hyperglycemia and new-onset diabetes.
Topics: COVID-19; Diabetes Mellitus; Humans; Hyperglycemia; Insulin; Magnesium Oxide; Pyruvaldehyde; SARS-Co | 2022 |
Methylglyoxal in COVID-19-induced hyperglycemia and new-onset diabetes.
Topics: COVID-19; Diabetes Mellitus; Humans; Hyperglycemia; Insulin; Magnesium Oxide; Pyruvaldehyde; SARS-Co | 2022 |
Methylglyoxal in COVID-19-induced hyperglycemia and new-onset diabetes.
Topics: COVID-19; Diabetes Mellitus; Humans; Hyperglycemia; Insulin; Magnesium Oxide; Pyruvaldehyde; SARS-Co | 2022 |
3 other studies available for pyruvaldehyde and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Elevated plasma level of the glycolysis byproduct methylglyoxal on admission is an independent biomarker of mortality in ICU COVID-19 patients.
Topics: Biomarkers; COVID-19; Glycolysis; Humans; Intensive Care Units; Pyruvaldehyde | 2022 |
Glycation-Driven Inflammation: COVID-19 Severity in Pregnant Women and Perinatal Outcomes.
Topics: COVID-19; Female; Glucose; Glycosylation; Humans; Infant, Newborn; Inflammation; Obesity; Overweight | 2022 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein S1 Induces Methylglyoxal-Derived Hydroimidazolone/Receptor for Advanced Glycation End Products (MG-H1/RAGE) Activation to Promote Inflammation in Human Bronchial BEAS-2B Cells.
Topics: Angiotensin-Converting Enzyme 2; COVID-19; Glycation End Products, Advanced; Humans; Inflammation; P | 2023 |